Legis Daily

Access to Prescription Digital Therapeutics Act of 2022

USA117th CongressHR-7051| House 
| Updated: 3/10/2022
Mike Thompson

Mike Thompson

Democratic Representative

California

Cosponsors (27)
Tom O'Halleran (Democratic)John Katko (Republican)Tom Cole (Republican)Guy Reschenthaler (Republican)David J. Trone (Democratic)Darren Soto (Democratic)Robert J. Wittman (Republican)Terri A. Sewell (Democratic)Jimmy Panetta (Democratic)Madeleine Dean (Democratic)Scott H. Peters (Democratic)Paul Tonko (Democratic)Angie Craig (Democratic)Daniel T. Kildee (Democratic)David B. McKinley (Republican)Ann M. Kuster (Democratic)Kurt Schrader (Democratic)Stephen F. Lynch (Democratic)G. K. Butterfield (Democratic)Doris O. Matsui (Democratic)Yvette D. Clarke (Democratic)Tom Emmer (Republican)Brian K. Fitzpatrick (Republican)Kevin Hern (Republican)Cheri Bustos (Democratic)Ted Budd (Republican)Fred Keller (Republican)

Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Access to Prescription Digital Therapeutics Act of 2022 This bill provides for Medicare and Medicaid coverage of prescription digital therapeutics (i.e., software applications that are used to prevent, manage, or treat medical conditions). The Centers for Medicare & Medicaid Services must establish a Medicare payment methodology for payments to manufacturers that takes into account certain factors (e.g., ongoing use); manufacturers must report specified information about private payors, subject to civil penalties.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 9, 2022
Introduced in House
Mar 9, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 10, 2022

Latest Companion Bill Action

S 117-3791
Introduced in Senate
Mar 10, 2022
Referred to the Subcommittee on Health.
  • March 9, 2022
    Introduced in House


  • March 9, 2022
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • March 10, 2022

    Latest Companion Bill Action

    S 117-3791
    Introduced in Senate


  • March 10, 2022
    Referred to the Subcommittee on Health.

Health

Related Bills

  • S 117-3791: Access to Prescription Digital Therapeutics Act of 2022
Business recordsCivil actions and liabilityComputers and information technologyDigital mediaHealth care costs and insuranceInternet, web applications, social mediaMedicaidMedicarePrescription drugs

Access to Prescription Digital Therapeutics Act of 2022

USA117th CongressHR-7051| House 
| Updated: 3/10/2022
Access to Prescription Digital Therapeutics Act of 2022 This bill provides for Medicare and Medicaid coverage of prescription digital therapeutics (i.e., software applications that are used to prevent, manage, or treat medical conditions). The Centers for Medicare & Medicaid Services must establish a Medicare payment methodology for payments to manufacturers that takes into account certain factors (e.g., ongoing use); manufacturers must report specified information about private payors, subject to civil penalties.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 9, 2022
Introduced in House
Mar 9, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 10, 2022

Latest Companion Bill Action

S 117-3791
Introduced in Senate
Mar 10, 2022
Referred to the Subcommittee on Health.
  • March 9, 2022
    Introduced in House


  • March 9, 2022
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • March 10, 2022

    Latest Companion Bill Action

    S 117-3791
    Introduced in Senate


  • March 10, 2022
    Referred to the Subcommittee on Health.
Mike Thompson

Mike Thompson

Democratic Representative

California

Cosponsors (27)
Tom O'Halleran (Democratic)John Katko (Republican)Tom Cole (Republican)Guy Reschenthaler (Republican)David J. Trone (Democratic)Darren Soto (Democratic)Robert J. Wittman (Republican)Terri A. Sewell (Democratic)Jimmy Panetta (Democratic)Madeleine Dean (Democratic)Scott H. Peters (Democratic)Paul Tonko (Democratic)Angie Craig (Democratic)Daniel T. Kildee (Democratic)David B. McKinley (Republican)Ann M. Kuster (Democratic)Kurt Schrader (Democratic)Stephen F. Lynch (Democratic)G. K. Butterfield (Democratic)Doris O. Matsui (Democratic)Yvette D. Clarke (Democratic)Tom Emmer (Republican)Brian K. Fitzpatrick (Republican)Kevin Hern (Republican)Cheri Bustos (Democratic)Ted Budd (Republican)Fred Keller (Republican)

Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 117-3791: Access to Prescription Digital Therapeutics Act of 2022
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Business recordsCivil actions and liabilityComputers and information technologyDigital mediaHealth care costs and insuranceInternet, web applications, social mediaMedicaidMedicarePrescription drugs